From Product to Patient: Shifting the focus of support programs in oncology

October 19, 2016

Empowered by the ease with which they can access information, today’s cancer patients seek a deeper understanding about their diagnoses, underlying diseases or health conditions and potential treatment options, as well as the financial implications of clinical decisions made by their prescribers.
By Amy Grogg, PharmD, Senior Vice President, Strategy & Commercialization, AmerisourceBergen Specialty Group

But what does it all mean for pharma? In this era of greater healthcare information, transparency and access, manufacturers can find  success by engaging patients at an individual level. It’s time for true patient-centricity – a tailored approach to patient support, even for patients that struggle to engage in their own care.